Brought to you by:
SCVS issues call for abstracts as deadline approaches for 2025 symposium
The Society for Clinical Vascular Surgery (SCVS) has issued a call for abstracts for its 2025 Annual Symposium, with just under two weeks left until the deadline. Once again, the SCVS will give special consideration to papers deemed “collaboration abstracts”—those…
Eastern Vascular Society set to stage day of service during 2024 annual meeting
The Eastern Vascular Society (EVS) has incorporated a day of service into its 2024 annual meeting, being held in Charleston, South Carolina (Sept. 19–22). Leading vascular surgeons, alongside nurse practitioners and advanced practice partners, will educate local residents about their…
SVS sets modest dues increase to drive enhanced member benefits
The Society for Vascular Surgery (SVS) announced an increase in membership dues for 2024 for Active members, a strategic move aimed at enhancing support and resources for its members. This adjustment will bolster professional development opportunities, networking, advocacy and resources…
‘Choosing the right devices for the right patients’: Surgeon-scientist secures NIH funding to develop MRI technique for precision PAD care
Michael Conte, MD, recently used his 2024 Veith Lecture to call on young vascular surgeons on the peripheral arterial disease (PAD) frontlines to drive the space forward amid a great unmet need. The professor and chief of vascular and endovascular…
Physician-modified endografts ‘safe and effective’ for thoracoabdominal and complex AAA repair
Researchers have reported a 94% technical success rate among other key findings from a recent international, multicentre, single-arm cohort study of physician-modified endografts (PMEGs) for thoracoabdominal and complex abdominal aortic aneurysm (AAA) repair. The work has been published in the…
SCOREPAD seeks to address ‘alarmingly high’ mortality in CLTI patients with underlying coronary disease
A new research letter underscores the need to improve long-term survival following lower extremity revascularization for chronic limb-threatening ischemia (CLTI), setting out a randomized controlled trial to examine the impact of coronary artery ischemia testing in these patients. The letter,…
Survey of off-label treatment of complex repair pinpoints factors behind underreported outcomes data
The potential for cost and time to be key factors in low levels of outcomes data reporting emerged during a national survey of the off-label use of approved endovascular devices for complex aortic aneurysm repair. Grayson S. Pitcher, MD, an…
Societies seek consensus on NIVL management amid ‘paucity of rigorous data’
The diagnosis and management of non-thrombotic iliac vein lesions (NIVL) is the focus of a newly published set of consensus statements from the Vascular Interventional Advances (VIVA) Foundation, the American Venous Forum (AVF), and the American Vein and Lymphatic Society…
SVS urges revisions for independent cardiology certification board
The Society for Vascular Surgery (SVS) has expressed conditional support for cardiology establishing an independent certification board but objects to provisions in the current American Board of Cardiovascular Medicine (ABCVM) proposal as they conflict significantly with the mission and requirements…
Centerline Biomedical receives FDA 510(k) clearance for new IOPS Viewpoint catheter
Centerline Biomedical recently announced that its Intra-Operative Positioning System (IOPS) Viewpoint catheter has received Food and Drug Administration (FDA) 510(k) clearance. The Viewpoint catheter is the most recent addition to the company’s patented IOPS portfolio. A press release details that Viewpoint—a…